(-)Epigallocatechingallate protects the mitochondria against the deleterious effects of lipids, calcium and adenosine triphosphate in isoproterenol induced myocardial infarcted male Wistar rats

Journal of Applied Toxicology

Volumn 28, Issue 8, 2008, Pages 938-944

  Devika, P T ^a   Prince, P Stanely Mainzen ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

( )epigallocatechin gallate; Adenosine triphosphate; Isoproterenol; Mitochondrial lipids; Myocardial infarction

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; CHOLESTEROL; EPIGALLOCATECHIN GALLATE; FATTY ACID; ISOPRENALINE; LIPID; LIPID PEROXIDE; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; HEART INFARCTION; HEART MITOCHONDRION; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WISTAR RAT;

ADENOSINE TRIPHOSPHATE; ADRENERGIC BETA-AGONISTS; ANIMALS; CALCIUM; CATECHIN; CHOLESTEROL; FATTY ACIDS, NONESTERIFIED; ISOPROTERENOL; LIPID PEROXIDES; LIPIDS; MALE; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; PHOSPHOLIPIDS; PROTECTIVE AGENTS; RATS; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES;

RATTUS; RATTUS NORVEGICUS;

EID: 55549114375     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1357     Document Type: Article

References (48)

1. Allen KK, Almeida A, Bates TB, Clark JB. 1995. Changes of respiratory chain activity in mitochondrial and synaptosomal fractions isolated from the gerbil brain after graded ischemia. J. Neurochem. 64: 2222-2229.
2. Arts IC, Hollman PC, Feskens EJ, Bueno de mesquite HB, Kromhout D. 2001. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am. J. Clin. Nutr. 70: 227-232.
3. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. 2006. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from one-year proof-of-principle study. Cancer Res. 66: 1234-1240.
4. Blasig IE, Blasig R, Lowe H. 1984. Myocardial lipid peroxidation during isoproterenol induced blood flow reduction in rat myocardium. Biomed. Biochem. Acta 43: 171-174.
5. Bonting SL. 1970. Membrane and Ion Transport. Wiley Interscience: London; 257.
6. Dale-Nagle G, Ferreira D, Zhou YD. 2006. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry 67: 1849-1855.
7. Devika PT, Stanely Mainzen Prince P. 2007. Protective effect of (?)epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: a histopathological study. Biomed. Pharmacother. (online at www.sciencedirect.com).
8. Devika PT, Stanely Mainzen Prince P. 2008a. (?)Epigallocatechingallate (EGCG) prevents isoproterenol induced cardiac toxicity by stabilizing cardiac marker enzymes and membrane bound-ATPases. J. Pharm. Pharmac. 60: 125-133.
9. Devika PT, Stanely Mainzen Prince P. 2008b. Preventive effect of (?)epigallocatechin gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol induced myocardial infarcted Wistar rats. Chem. Biol. Interact 172: 245-252.
10. Donald Voet JG. 1995. ATP Driven Active Transport, Voet D, Voet JU (eds). Wiley: Chichester; 524.
11. Falholt K, Lund B, Falholt W. 1973. An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin. Chim. Acta 46: 105-111.
12. Farber JL, Young EE. 1981. Accelerated phospholipids degradation in anoxic rat hepatocytes. Arch. Biochem. Biophys. 211: 3123-380.
13. Folch J, Lees M, Sloane SGH. 1957. A simple method for isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
14. Foster LB, Dunn RT. 1973. Stable reagents for determination of serum triglycerides by colorimetric Hantzsch condensation method. Clin. Chem. 19: 338-340.
15. Fraga CG, Leibovitz BE, Tappel AL. 1988. Lipid peroxidation measured as thiobarbituric acid reactive substances in tissue slices: characterization and comparison with homogenate and microsomes. Free Radic. Biol. Med. 4: 155-161.
16. 2+ ATPase by oxygen through thiol- and lipid dependent mechanisms. Biochem. Biophys. Acta 862: 8-16.
17. Isbrucker RA, Edwards JA, Wolz E, Davidovich A, Bausch J. 2006. Safety studies on epigallocatechin gallate (EGCG) preparations Part 2: dermal, acute and short-term toxicity studies. Food Chem. Toxicol. 44: 636-650.
18. Jackson G. 1985. Laboratory diagnosis of myocardial ischemia. In Invasive Cardiology, Cardiovascular Clinics, Shroeder JS (ed.). Davis: Philadelphia, PA; 45-66.
19. Janke J, Fleckenstein A, Doring HJ, Leder O. 1975. Key role of intracellular calcium overload in acute necrosis of the myocardium. Cardioprotection with verapamil. Minerva Med. 66: 1846-1852.
20. Jiang ZY, Hunt JV, Wolff SP. 1992. Ferrous iron oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low-density lipoprotein. Anal. Biochem. 202: 384-389.
21. + ATPase activity induced by free radicals and by ischemia of kidney. Am J. Physiol. 254: 330-337.
22. Katiyar SK, Mukhtar H. 1997. Tea antioxidants in cancer chemoprevention. J. Cell Biochem. 27: 59-67.
23. Koh SH, Kim SH, Kwon H, Park Y, Kim KS, Song CW, Kim J, Kim MH, Yu HJ, Henkel JS, Jung HK. 2003. Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical stress induced apoptosis through its effect on phosphoinositide 3-kinase/AKt and glycogen synthase kinase-3. Brain. Res. Mol. Brain. Res. 118: 72-81.
24. 1-ATPase. J. Biol. Chem. 261: 14851-14856.
25. Lowry OH, Rosebrough MJ, Farr AL, Randall RJ. 1951. Protein measurement with Folin-phenol reagent. J. Biol. Chem. 193: 265-275.
26. Manjula TS, Geetha A, Ramesh TG, Devi CS. 1992. Reversal of changes of myocardial lipids by chronic administration of aspirin in isoproterenol-induced myocardial damage in rats. Ind. J. Physiol. Pharmac. 36: 47-50.
27. + ATPase during stress. Bull. Exp. Biol. Med. 96: 42-44.
28. Milei J, Nunez RG, Rapaport M. 1978. Pathogenesis of isoproterenol induced myocardial lesions: its relation to human coagulate myocytolysis. Cardiol. 63: 139-151.
29. Mochizuki M, Hasegawa N. 2005. Protective effect of (?)-epigallocatechin gallate on acute experimental colitis. J. Health Sci. 51: 362-364.
30. Nirmala C, Puvanakrishnan R. 1996. Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol. Cell. Biochem. 159: 85-93.
31. Panagia V, Pierce GN, Dhalla KS, Ganguly PK, Beamish RE, Dhalla NS. 1985. Adaptive charges in subcellular calcium transport during catecholamine-induced cardiomyopathy. J. Mol. Cell. Cardiol. 17: 411-420.
32. Rajadurai M, Stanely Mainzen Prince P. 2006. Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: biochemical and histopathological evidences. Toxicology 228: 259-268.
33. Rice-Evans CA, Miller NJ, Paganga G. 1996. Structure-antioxidant activity relationship of flavonoids and phenolic acids. Free Radic. Biol. Med. 20: 933-956.
34. Richards RT, Sharma HM. 1991. Free radicals in health and disease. Ind. J. Clin Practice. 2: 15-26.
35. Rona G. 1985. Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol. 17: 291-306.
36. Rouslin W, Macgee J, Gupte S, Wesselman A, Epps DE. 1982. Mitochondrial cholesterol content and membrane properties in porcine mitochondrial ischemia. Am. J. Physiol. 242: 254-259.
37. Saffari Y, Sadrzadeh SM. 2004. Green tea metabolite, (?)epigallocatechin gallate protects membranes against oxidative damage in vitro. Life Sci. 74: 1513-1518.
38. Taegtmeyer H. 1998. Energy substrate metabolism as target for pharmacotherapy in ischemia and reperfused heart muscle. Heart Metabol. 1: 5-9.
39. Taegtmeyer H, Roberts AF, Raine AE. 1985. Energy metabolism in reperfused heart muscle: metabolic correlates to return of function. J. Am. Coll. Cardiol. 6: 864-870.
40. Takasawa M, Hayakawa M, Sugiyama S, Hattori K, Ito T, Ozawa T. 1993. Age-associated damage in mitochondrial function in rat hearts. Exp. Gerontol. 28: 269-280.
41. Thompson JA, Hess ML. 1986. The oxygen free radical system; a fundamental mechanism in the production of myocardial necrosis. Prog. Cardiovasc. Dis. 28: 449-462.
42. Veitch K, Hombroeckx A, Caucheteux D, Pouleur H, Hue L. 1992. Global ischemia induces a biphasic response of the mitochondrial respiratory chain. Anoxic pre-perfusion protects against ischaemic damage. Biochem. J. 281: 709-715.
43. Williams JR, Coorkey BE. 1967. Assay of intermediates of the citric acid cycle and related compounds by flourimetric enzymatic methods. In Methods in Enzymology, Lowenstein JM (eds). Academic Press: New York; 488-492.
44. +)-ATPase ATP hydrolyzing activity in human erythrocytes. Biochem. Biophys. Acta 727: 39-44.
45. Yogeeta SK, Raghavendran HR, Gnanapragasam A, Subhashini R, Devaki T. 2006. Ferulic acid with ascorbic acid synergistically extenuates the mitochondrial dysfunction during β-adrenergic catecholamine induced cardiotoxicity in rats. Chem. Biol. Interact. 163: 160-169.
46. Zhao B, Guo Q, Xin W. 2001. Free radical scavenging by green tea polyphenols. Meth. Enzymol. 77: 334-350.
47. Zilversmit DB, Davis AK. 1950. Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. J. Lab. Clin. Med. 35: 155-160.
48. Zlatkis A, Zak B, Boyle AJ. 1953. A new method for the direct determination of serum cholesterol. J. Clin. Med. 41: 486-492.